BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 4, 2015
View Archived Issues
Boehringer Ingelheim and MD Anderson Cancer Center collaborate in pancreatic ductal adenocarcinoma
Read More
Pfizer outlines the discovery of the myeloperoxidase inhibitor PF-06282999
Read More
NIAID reports results from phase I trial of anti-HIV antibody VRC-01
Read More
Adaptimmune and Universal Cells collaborate to develop universal allogeneic T-cell therapies
Read More
Novo Nordisk starts phase I trial comparing NNC-0143-0406 and insulin aspart
Read More
Phase II dose determined for tremelimumab plus gefitinib in EGFR-mutant NSCLC
Read More
Lilly's Portrazza available as first-line therapy for metastatic squamous NSCLC
Read More
First-in-human results lead to phase II planning for ABTL-0812
Read More
Ra Pharmaceuticals initiates phase I trial of complement C5 inhibitor RA-101495
Read More
Novel ADCs have a significant cytotoxic effect both in vitro and in vivo
Read More
Termination of Egalet's collaboration with Shionogi for S-718632
Read More
Biophytis Institut and Universite Pierre et Marie Curie patent GDF-8 inhibitors
Read More
Abide Therapeutics and Scripps Research Institute disclose MAGL inhibitors
Read More
Genzyme announces Nampt inhibitors
Read More
Allergan presents FPR2 ligands
Read More
FDA grants fast track designation to oliceridine for moderate to severe acute pain
Read More
Amgen files MAA for biosimilar adalimumab ABP-501
Read More
Coagadex now available in U.S.
Read More
FDA clears IND for study of Aramchol in patients with HIV-associated lipodystrophy and NAFLD
Read More
Sunesis establishes compassionate use program for vosaroxin in AML
Read More
Phase I studies evaluate repurposed mibefradil with radiotherapy or chemotherapy in glioma patients
Read More
Synthetic Biologics releases results from first phase IIa study of SYN-004
Read More
Novel enolase inhibitor shows in vivo antineoplastic activity
Read More
FDA grants rare pediatric disease designation to Kevetrin for retinoblastoma
Read More
Biovista begins drug repositioning collaboration with Astellas
Read More
Galenica confirms plans to split group in 2016
Read More